Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date August 13, 2020 · Filed August 17, 2020
Section 16 reporting ended · disclosed 2020-08-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 22,982 |
Reported balance
After 2020-08-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-08-13 · Grant · Acquired 5,235 · Balance 22,982 F1: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on August 13, 2020, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. F2: Effective August 14, 2020, executive is no longer subject to reporting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on August 13, 2020, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2: Effective August 14, 2020, executive is no longer subject to reporting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2020 Filed Aug 17, 2020 22:37 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 5,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023726 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,982 F1 · kind: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on August 13, 2020, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. F2 · balance_after: Effective August 14, 2020, executive is no longer subject to reporting. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,000 | $172.63 | $517,903.50 |
DisclosureSEC source: 0001127602-20-005078 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,670 F1 · price: This transaction was executed in multiple trades at prices ranging from $172.59 to 172.65. The price reported above reflects the weighted average sale price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 23:28 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,000 | $146.10 | $438,285.00 |
DisclosureSEC source: 0001127602-19-033779 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,670 F1 · price: This transaction was executed in multiple trades at prices ranging from $146.07 to $146.19. The price reported above reflects the weighted average sale price. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 8,775 | $146.34 | $1,284,133.50 |
DisclosureSEC source: 0001127602-19-033565 · form4.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,670 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 15,731 | $146.34 | $2,302,074.54 |
DisclosureSEC source: 0001127602-19-033565 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,445 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:19 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,199 | $143.88 | $172,512.12 |
DisclosureSEC source: 0001127602-19-032675 · form4.xml · nonDerivative · entry 3 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,714 F4 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:19 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,189 | $143.88 | $171,073.32 |
DisclosureSEC source: 0001127602-19-032675 · form4.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,913 F3 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018. Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 01:19 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,206 | $143.88 | $173,519.28 |
DisclosureSEC source: 0001127602-19-032675 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,102 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 117.14 shares of ResMed stock purchased on October 31, 2019, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 20:20 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031079 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,191 F1 · kind: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on October 24, 2019, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. F1 · shares: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on October 24, 2019, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 01:22 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026663 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,410 F1 · shares: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on August 14, 2019, when the compensation committee certified that the performance metrics were met. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:49 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 12,306 | $127.06 | $1,563,563.44 |
DisclosureSEC source: 0001127602-19-025470 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,215 F1 · price: This transaction was executed in multiple trades at prices ranging from $126.62 to $127.60. The price reported above reflects the weighted average sale price. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Stock Option Plan · Derivative | 21,616 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · derivative · entry 12 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 21,616 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Stock Option Plan · Derivative | 4,907 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · derivative · entry 11 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 4,907 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 21,616 | $105.00 | $2,269,680.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 8 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 21,616 | $58.24 | $1,258,915.84 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 7 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,907 | $105.00 | $515,235.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 6 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 4,907 | $58.24 | $285,783.68 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 5 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Stock Option Plan · Derivative | 1,079 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · derivative · entry 10 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,616 Underlying: ResMed Common Stock · 1,079 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Stock Option Plan · Derivative | 244 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · derivative · entry 9 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,907 Underlying: ResMed Common Stock · 244 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,079 | $105.05 | $113,348.95 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 4 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,079 | $58.24 | $62,840.96 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 3 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 244 | $105.05 | $25,632.20 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 244 | $58.24 | $14,210.56 |
DisclosureSEC source: 0001127602-19-014605 · form4.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 18:37 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 45 | $106.94 | $4,812.30 |
DisclosureSEC source: 0001567619-18-008414 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F2 · shares: Disposition to issuer for corrected tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 18:37 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 58 | $106.94 | $6,202.52 |
DisclosureSEC source: 0001567619-18-008414 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,449 F1 · shares: Disposition to issuer for corrected tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 17:08 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,800 | $111.56 | $200,808.00 |
DisclosureSEC source: 0001567619-18-007209 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,507 F1 · price: This transaction was executed in multiple trades at prices ranging from $111.55 to $111.57. The price reported above reflects the weighted average sale price. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 20:55 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 7,137 | $104.18 | $743,532.66 |
DisclosureSEC source: 0001567619-18-006921 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,307 F2 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 20:55 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 12,793 | $104.18 | $1,332,774.74 |
DisclosureSEC source: 0001567619-18-006921 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,444 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 20:25 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 939 | $106.94 | $100,416.66 |
DisclosureSEC source: 0001567619-18-006838 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,651 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 20:25 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,149 | $106.94 | $122,874.06 |
DisclosureSEC source: 0001567619-18-006838 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,590 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 128.63 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 21:52 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-004794 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,610 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on October 29, 2018, when the compensation committee certified that the performance metrics were met. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 16:49 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-001349 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,642 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met. F2 · balance_after: Includes 142.65 shares of ResMed stock purchased on April 30,2018, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:02 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,000 | $100.12 | $200,240.00 |
DisclosureSEC source: 0001140361-18-004936 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,204 F1 · price: This transaction was executed in multiple trades at prices ranging from $100.05 to $100.14. The price reported above reflects the weighted average sale price. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 17:20 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,331 | $84.63 | $112,642.53 |
DisclosureSEC source: 0001140361-17-044075 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,204 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 17:20 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,540 | $84.63 | $299,590.20 |
DisclosureSEC source: 0001140361-17-044075 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,535 F1 · kind: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance. F2 · shares: Shares earned based on performance at 57% of the target award. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 23:59 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 909 | $83.06 | $75,501.54 |
DisclosureSEC source: 0001140361-17-042904 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,995 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 23:59 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 794 | $83.06 | $65,949.64 |
DisclosureSEC source: 0001140361-17-042904 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,904 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. F2 · balance_after: Includes 177 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 20:18 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038528 · doc1.xml · nonDerivative · entry 2 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,520 F2 · shares: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 20:18 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038528 · doc1.xml · nonDerivative · entry 1 McHale Richard · CIK 0001715326 · President, RC Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.